-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Senti Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2021 to Q3 2025.
- Senti Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$1.18M, a 91.4% increase year-over-year.
- Senti Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $18.7M.
- Senti Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $8.25M, a 11.5% decline from 2023.
- Senti Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $9.32M, a 24.9% decline from 2022.
- Senti Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $12.4M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)